Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Rating of “Moderate Buy” from Analysts
Neurogene Inc. (NASDAQ:NGNE – Get Free Report) has received an average rating of “Moderate Buy” from the seven research firms that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price objective among […]
Neurogene Inc. (NASDAQ:NGNE – Get Free Report) has received an average rating of “Moderate Buy” from the seven research firms that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price objective among […]
